Desmoplastic Small Round Cell Tumour: New Hope in Treatment

📅 Date: 5 February 2026
⏰ Time: 8:30PM – 9:30PM

This Rare Tumor Board session focuses on Desmoplastic Small Round Cell Tumor (DSRCT), a rare and highly aggressive pediatric and young adult malignancy. Experts from international centers share insights on the challenges of diagnosis, including molecular and pathological complexities, as well as current multimodal treatment approaches such as chemotherapy, surgery, and radiotherapy.

The webinar also highlights emerging therapies—including targeted treatments, immunotherapy, and novel approaches like CAR-T and antibody-drug conjugates—that offer new hope in improving outcomes. Real-world data and case studies are presented, alongside discussions on future collaborative strategies to advance care for this ultra-rare disease.